Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ OGT 2115

Antiangiogenic. Heparanase inhibitor

Supplier:  Tocris Bioscience™ 2710/1

 View more versions of this product

Catalog No. 27-101-R


Add to Cart
This item is not returnable. View return policy

Description

Description

OGT 2115 is a heparanase inhibitor (IC50 = 0.4 μM) that displays no major inhibition of human cytochrome P450 isoenzymes (IC50 > 30 μM). Exhibits antiangiogenic properties in vitro (IC50 = 1 μM).
Specifications

Specifications

2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid
>98%
Soluble to 10mM in DMSO
Observed MW: 495.3
853929-59-6
1 mg
C24H16BrFN2O4
97%
Safety and Handling

Safety and Handling

Recommended Storage : Store at Room Temperature

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

For Research Use Only